|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0016360,
umls-concept:C0023413,
umls-concept:C0024623,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0246415,
umls-concept:C0282460,
umls-concept:C0679729,
umls-concept:C0699967,
umls-concept:C1518578
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-3-24
|
|
pubmed:abstractText |
We assessed the efficacy and safety profile of a docetaxel (Taxotere; Sanofi-Aventis, France), fluorouracil (FU), and leucovorin (LV) combination (TFL), as first-line chemotherapy in patients with advanced gastric cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1436-3291
|
|
pubmed:author |
pubmed-author:BafaloukosDimitriosD,
pubmed-author:BamiasAristotelisA,
pubmed-author:FountzilasGeorgeG,
pubmed-author:JaninisDimitriosD,
pubmed-author:KalofonosHaralabos PHP,
pubmed-author:KosmidisParisP,
pubmed-author:PapakostasPavlosP,
pubmed-author:SakantamisAthanassiosA,
pubmed-author:SkarlosDimosthenisD,
pubmed-author:TsavdaridisDimitriosD,
pubmed-author:XirosNikosN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
26-31
|
|
pubmed:dateRevised |
2007-1-8
|
|
pubmed:meshHeading |
pubmed-meshheading:16557433-Adult,
pubmed-meshheading:16557433-Aged,
pubmed-meshheading:16557433-Aged, 80 and over,
pubmed-meshheading:16557433-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16557433-Female,
pubmed-meshheading:16557433-Fluorouracil,
pubmed-meshheading:16557433-Humans,
pubmed-meshheading:16557433-Leucovorin,
pubmed-meshheading:16557433-Male,
pubmed-meshheading:16557433-Maximum Tolerated Dose,
pubmed-meshheading:16557433-Middle Aged,
pubmed-meshheading:16557433-Stomach Neoplasms,
pubmed-meshheading:16557433-Survival Rate,
pubmed-meshheading:16557433-Taxoids
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.
|
|
pubmed:affiliation |
Oncology Department, Hippokration General Hospital, 108, Vas.Sofias Avenue, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
